Publication & Citation Trends
Most Cited Works
Publications
25 total
Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial
Cited by 86
OpenAlex
A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study PDF
Cited by 28
OpenAlex
Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer
Cited by 452
OpenAlex
Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology Group
Cited by 177
OpenAlex
Cisplatin-gemcitabine, vs. cisplatin-gemcitabine-vinorelbine, vs. cisplatin-gemcitabine-paclitaxel in advanced non-small-cell lung cancer. First-stage analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial
Cited by 16
OpenAlex
Second-line chemotherapy with paclitaxel, cisplatin and gemcitabine in pre-treated sensitive cisplatin-based patients with advanced non-small cell lung cancer.
Cited by 13
OpenAlex
Gemcitabine + vinorelbine (GV) yields better survival than vinorelbine (V) alone in elderly non-small cell lung cancer (NSCLC) patients. Final analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial
Cited by 11
OpenAlex
Interim Analysis of a Phase III Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine vs. Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer. A Southern Italy Cooperative Oncology Group Study
Cited by 10
OpenAlex
Research Topics
Lung Cancer Treatments and Mutations
(17)
Lung Cancer Research Studies
(14)
Cancer Treatment and Pharmacology
(10)
Lung Cancer Diagnosis and Treatment
(7)
Cancer therapeutics and mechanisms
(4)
Frequent Co-Authors
Affiliations
Ospedale Antonio Cardarelli
Medical Center Hospital
Fatebenefratelli Hospital
Tumour Institute of Tuscany
Istituto Tumori Bari